AU2002258387A1 - Rat toxicologically relevant genes and uses thereof - Google Patents

Rat toxicologically relevant genes and uses thereof

Info

Publication number
AU2002258387A1
AU2002258387A1 AU2002258387A AU2002258387A AU2002258387A1 AU 2002258387 A1 AU2002258387 A1 AU 2002258387A1 AU 2002258387 A AU2002258387 A AU 2002258387A AU 2002258387 A AU2002258387 A AU 2002258387A AU 2002258387 A1 AU2002258387 A1 AU 2002258387A1
Authority
AU
Australia
Prior art keywords
rat
relevant genes
toxicologically relevant
toxicologically
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002258387A
Inventor
Spencer B. Farr
Georgia Farris
Samuel H. Hicken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phase-1 Molecular Toxicology Inc
Original Assignee
Phase-1 Molecular Toxicology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phase-1 Molecular Toxicology Inc filed Critical Phase-1 Molecular Toxicology Inc
Publication of AU2002258387A1 publication Critical patent/AU2002258387A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2002258387A 2001-01-29 2002-01-29 Rat toxicologically relevant genes and uses thereof Abandoned AU2002258387A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26493301P 2001-01-29 2001-01-29
US60/264,933 2001-01-29
US30816101P 2001-07-26 2001-07-26
US60/308,161 2001-07-26
PCT/US2002/002935 WO2002066682A2 (en) 2001-01-29 2002-01-29 Rat toxicologically relevant genes and uses thereof

Publications (1)

Publication Number Publication Date
AU2002258387A1 true AU2002258387A1 (en) 2002-09-04

Family

ID=26950838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002258387A Abandoned AU2002258387A1 (en) 2001-01-29 2002-01-29 Rat toxicologically relevant genes and uses thereof

Country Status (5)

Country Link
EP (1) EP1368499A2 (en)
JP (1) JP2004535776A (en)
AU (1) AU2002258387A1 (en)
CA (1) CA2440008A1 (en)
WO (1) WO2002066682A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
US8222005B2 (en) * 2003-09-17 2012-07-17 Agency For Science, Technology And Research Method for gene identification signature (GIS) analysis
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
WO2008069342A1 (en) * 2006-12-05 2008-06-12 Incorporated Administrative Agency National Agriculture And Food Research Organization Probe for determination of allergenicity or anti-allergenicity
JP5763530B2 (en) 2008-06-10 2015-08-12 サンガモ バイオサイエンシーズ， インコーポレイテッド Methods and compositions for the generation of Bax- and Bak-deficient cell lines
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
CN112516125B (en) * 2020-12-23 2024-03-15 西北农林科技大学 Application of tyrosine in preparing medicine for preventing and treating intravascular hemolysis induced by puerarin injection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002523112A (en) * 1998-08-28 2002-07-30 インサイト・ファーマスーティカルズ・インコーポレイテッド Toxicological markers

Also Published As

Publication number Publication date
WO2002066682A3 (en) 2002-12-19
CA2440008A1 (en) 2002-08-29
WO2002066682A2 (en) 2002-08-29
EP1368499A2 (en) 2003-12-10
JP2004535776A (en) 2004-12-02

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
WO2003018621A8 (en) Genes
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002350105A1 (en) Novel quinazolines and uses thereof
AU2002356664A1 (en) Beta-amino-alpha-cyanoacrylates and their use as herbicides
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002323484A1 (en) Insulin related transcription factor and uses thereof
EP1392106A4 (en) Tyra genes and uses thereof
AU2002247269A1 (en) Genes and polymorphisms associated with cardiovascular disease and their use
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002258387A1 (en) Rat toxicologically relevant genes and uses thereof
AU2002323286A1 (en) Human toxicologically relevant genes and arrays
AU2002355994A1 (en) Display
AU2002257430A1 (en) Androgen-mediated neuroprotection and uses thereof
AU2002255704A1 (en) Novel anti-adhesive compounds and uses thereof
AU2001276686A1 (en) Human and rat abca2 genes
AU2002240921A1 (en) Medane genes and proteins
AU2002322224A1 (en) Isp-1 and ctb-1 genes and uses thereof
AU2002332680A1 (en) Improved umbrella
AU2002354461A1 (en) Chitosanase and use thereof
AU2002210960A1 (en) Novel disease-associated gene and use thereof
AU6497700A (en) Novel transporter-like genes and uses therefor
AU2003220913A1 (en) Novel g protein-coupled recepotrs and genes thereof
AU2002233730A1 (en) Agarase and gene thereof
AU2002322287A1 (en) Novel idolinones and uses thereof

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase; withdrawn by applicant
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 17, NO 31, PAGE(S) 11102 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN, PATENTS CEASED OR EXPIRED - 2002 DELETE ALL REFERENCE TO 2002258387.